Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion type Assertion NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_head.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion description "[Further, at least two studies now show that the inactivating NAD(P)H:quinone acceptor oxidoreductase (NQO1) C609T polymorphism is positively associated with leukemias arising in the first 1-2 years of life and polymorphisms in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene have been associated with adult and childhood ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_provenance.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion evidence source_evidence_literature NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_provenance.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion SIO_000772 15967214 NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_provenance.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion wasDerivedFrom befree-2016 NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_provenance.
- NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_assertion wasGeneratedBy ECO_0000203 NP500282.RAiKzc1ti1sOMW0623lhbHVf-s-pJE4-UFeZO860kcHbc130_provenance.